Invitrogen Entering Gene Analysis Market Via Research Genetics
This article was originally published in The Gray Sheet
Executive Summary
Invitrogen's acquisition of Research Genetics in a stock transaction valued at $158 mil. will allow the company's expanded sales force to offer products and services in four key areas of the genomic discovery cycle.